Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3',5'-dimethoxy-4e-stilbenol
2. 3',5'-dimethoxy-4trans-stilbenol
3. 3',5'-dimethoxy-resveratrol
4. 3,5-dimethoxy-4'-hydroxy-trans-stilbene
5. 4-((e)-2-(3,5-dimethoxyphenyl)ethenyl)phenol
6. 4trans-(2-(3,5-dimethoxyphenyl)ethenyl)phenol
7. Phenol, 4-((1e)-2-(3,5-dimethoxyphenyl)ethenyl)-
8. Pterostilbene, (e)-
9. Trans-3,5-dimethoxy-4'-hydroxystilbene
10. Trans-pterostilbene
1. 537-42-8
2. Trans-pterostilbene
3. 4-(3,5-dimethoxystyryl)phenol
4. (e)-4-(3,5-dimethoxystyryl)phenol
5. 4-[(e)-2-(3,5-dimethoxyphenyl)ethenyl]phenol
6. 18259-15-9
7. 3',5'-dimethoxy-4-stilbenol
8. 4-[(e)-2-(3,5-dimethoxyphenyl)vinyl]phenol
9. Pterostilbene, (e)-
10. Pterostilben
11. 3,5-dimethoxy-4'-hydroxy-trans-stilbene
12. Trans-3,5-dimethoxy-4'-hydroxystilbene
13. Phenol, 4-[(1e)-2-(3,5-dimethoxyphenyl)ethenyl]-
14. Chembl83527
15. Chebi:8630
16. 4-((e)-2-(3,5-dimethoxyphenyl)ethenyl)phenol
17. 26r60s6a5i
18. 4-[(1e)-2-(3,5-dimethoxyphenyl)ethenyl]phenol
19. 3,5-dimethoxy-4'-hydroxystilbene
20. Phenol, 4-[2-(3,5-dimethoxyphenyl)ethenyl]-
21. Phenol, 4-((1e)-2-(3,5-dimethoxyphenyl)ethenyl)-
22. Mfcd00238710
23. Smr000440694
24. Pterostilbene, Pterocarpus Marsupium
25. 4-((1e)-2-(3,5-dimethoxyphenyl)ethenyl)phenol
26. Pteropure
27. Unii-26r60s6a5i
28. Tero-still-bean
29. 4'-hydroxy-3,5-dimethoxy-trans-stilbene
30. Cpd000440694
31. 4-stilbenol, 3',5'-dimethoxy-, (e)-
32. Phenol, 4-[(1z)-2-(3,5-dimethoxyphenyl)ethenyl]-
33. 3,5-di-o-methylresveratrol
34. Schembl20063
35. Mls000759434
36. Mls000863581
37. Mls001424135
38. Schembl563218
39. Pterostilbene [who-dd]
40. Gtpl2681
41. Megxp0_000345
42. Dtxsid9041106
43. Acon1_000305
44. 4'-hydroxy-3,5-dimethoxystilbene
45. Hms2051b10
46. Hms2270j16
47. Trans-1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)ethylene
48. Zinc899213
49. Act03896
50. Albb-013778
51. Amy24840
52. Bcp22675
53. Hy-n0828
54. (e)-3',5'-dimethoxy-4-stilbenol
55. Bdbm50131688
56. Lmpk13090015
57. Nsc613735
58. S3937
59. 4''-hydroxy-3,5-dimethoxy Stilbene
60. Akos000277651
61. Akos025310510
62. Ac-5283
63. Ccg-101015
64. Cs-w008773
65. Eh-301 Component Pterostilbene
66. Nc00265
67. Nsc-613735
68. (e)-4'-hydroxy-3,5-dimethoxystilbene
69. Pterostilbene, >=97% (hplc), Solid
70. Ncgc00180691-01
71. As-13710
72. Ls-14484
73. 3,5-dimethoxy-4''-hydroxyl-trans-stilbene
74. Bb 0262300
75. N2126
76. P1924
77. 4-[2-(3,5-dimethoxy-phenyl)-vinyl]-phenol
78. Phenol,4-[2-(3,5-dmethoxyphenyl)ethenyl]-
79. (e)-1-hydroxy-4-(3,5-dimethoxy)styrylbenzene
80. E 4-[2-(3,5-dimethoxy-phenyl)-vinyl]-phenol
81. 259p159
82. 4-[(e)-2-(3,5-dimethoxy-phenyl)-vinyl]-phenol
83. A829757
84. J-523927
85. Phenol, 4-[(e)-2-(3,5-dimethoxyphenyl)ethenyl]-
86. Q2908011
87. W-203025
88. Phenol, 4-(2-(3,5-dimethoxyphenyl)ethenyl)-, (e)-
89. 4-[(e)-2-(3,5-dimethoxyphenyl)vinyl]phenol;pterostilbene
90. Ncgc00180691-03!4-[(e)-2-(3,5-dimethoxyphenyl)ethenyl]phenol
| Molecular Weight | 256.30 g/mol |
|---|---|
| Molecular Formula | C16H16O3 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 256.109944368 g/mol |
| Monoisotopic Mass | 256.109944368 g/mol |
| Topological Polar Surface Area | 38.7 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 270 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Pterostilbene has known human metabolites that include (2S,3S,4S,5R)-6-[4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Pterostilbene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pterostilbene, including repackagers and relabelers. The FDA regulates Pterostilbene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pterostilbene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pterostilbene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pterostilbene supplier is an individual or a company that provides Pterostilbene active pharmaceutical ingredient (API) or Pterostilbene finished formulations upon request. The Pterostilbene suppliers may include Pterostilbene API manufacturers, exporters, distributors and traders.
click here to find a list of Pterostilbene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pterostilbene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pterostilbene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pterostilbene GMP manufacturer or Pterostilbene GMP API supplier for your needs.
A Pterostilbene CoA (Certificate of Analysis) is a formal document that attests to Pterostilbene's compliance with Pterostilbene specifications and serves as a tool for batch-level quality control.
Pterostilbene CoA mostly includes findings from lab analyses of a specific batch. For each Pterostilbene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pterostilbene may be tested according to a variety of international standards, such as European Pharmacopoeia (Pterostilbene EP), Pterostilbene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pterostilbene USP).
LOOKING FOR A SUPPLIER?
